20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Cisplatin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2001-281 - Rev 01
This Chemical Type CEP, issued on May 15, 2009, remains in force until August 10, 2016, ensuring its reliability within the pharmaceutical industry.
Substance Number 599 associated with this CEP further emphasizes